{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:40:16Z","timestamp":1760215216764,"version":"build-2065373602"},"reference-count":36,"publisher":"ALUNA","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Aim: In this study, we examine and discuss about the resistance of Staphylococcus aureus to common antibiotic classes in Najaf.\nMaterials and methods: Information on Staphylococcus aureus's resistance to drugs was collected from the directorate of health and analyzed.\nResults: It was found that Staphylococcus aureus exhibited resistance to cephalosporins that was comparable to that of penicillin. On the other hand, significant resistance to cefoxitine, ceftazidim, and penicillin was seen, further studies are required to evaluate the mechanism of antibiotic resistance responsible for such resistance.\nConclusions: the profile of resistance of Staphylococcus aureus is variable across antibiotic families. Inter-member differences have been noticed within the group, a pattern that more likely indicates resistance at the level of intracellular concentration of antibiotic rather than the mechanism of action. In addition, it has been noticed that the development of resistance is directly proportional to the frequency of use of antibiotics. Further studies are required to investigate the molecular mechanism of resistance.<\/jats:p>","DOI":"10.36740\/merkur202505108","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:58:02Z","timestamp":1760212682000},"page":"614-619","source":"Crossref","is-referenced-by-count":0,"title":["The profile of the resistance of Staphylococcus aureus against selected antibiotics in Najaf"],"prefix":"10.36740","volume":"53","author":[{"given":"Salim","family":"Kadhim","sequence":"first","affiliation":[{"name":"FACULTY OF PHARMACY, UNIVERSITY OF ALKAFEEL, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghufran Lutfi","family":"Ismaeel","sequence":"additional","affiliation":[{"name":"FACULTY OF PHARMACY, UNIVERSITY OF AL-AMEED, KARBALA, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Hamid","family":"Abdul-Hussein","sequence":"additional","affiliation":[{"name":"FACULTY OF PHARMACY, UNIVERSITY OF AL-AMEED, KARBALA, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan N.","family":"Najaf","sequence":"additional","affiliation":[{"name":"FACULTY OF PHARMACY, UNIVERSITY OF KUFA, NAJAF, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyad Kadhim","family":"Oleiwi","sequence":"additional","affiliation":[{"name":"DEPARTMENT OF PHARMACEUTICAL CHEMISTRY, FACULTY OF PHARMACY, UNIVERSITY OF KUFA, NAJAF, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547-69. doi: 10.1080\/21505594.2021.1878688.","DOI":"10.1080\/21505594.2021.1878688"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Gardete S, Tomasz A. Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest. 2014;124(7):2836-40. doi: 10.1172\/JCI68834.","DOI":"10.1172\/jci68834"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Tsuiji M, Shiohara K, Takei Y, Shinohara Y, et al. Selective cytotoxicity of staphylococcal \u03b1-hemolysin (\u03b1-toxin) against human leukocyte populations. Biol Pharm Bull. 2019;42(6):982-8. doi: 10.1248\/bpb.b18-01024.","DOI":"10.1248\/bpb.b18-01024"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Tayeb-Fligelman E, Tabachnikov O, Moshe A, et al. The cytotoxic Staphylococcus aureus PSM\u03b13 reveals a cross-\u03b1 amyloid-like fibril. Science. 2017;355(6327):831-3. doi: 10.1126\/science.aaf4901.","DOI":"10.1101\/452011"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Chino T, Nukui Y, Morishita Y, Moriya K. Morphological bactericidal fast-acting effects of peracetic acid, a high-level disinfectant, against Staphylococcus aureus and Pseudomonas aeruginosa biofilms in tubing. Antimicrob Resist Infect Control. 2017;6:1-7. doi: 10.1186\/s13756-017-0281-1.","DOI":"10.1186\/s13756-017-0281-1"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Khoshnood S, Heidary M, Asadi A, et al. A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. Biomed Pharmacother. 2019;109:1809-18. doi: 10.1016\/j.biopha.2018.10.131.","DOI":"10.1016\/j.biopha.2018.10.131"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Jama. 2007;298(15):1763-71. doi: 10.1001\/jama.298.15.1763.","DOI":"10.1001\/jama.298.15.1763"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Klein EY, Mojica N, Jiang W, et al. Trends in methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010-2014. Clin Infect Dis. 2017;65(11):1921-3. doi: 10.1093\/cid\/cix640.","DOI":"10.1093\/cid\/cix640"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Letek M. Alexander Fleming, the Discoverer of the antibiotic effects of penicillin. 2020 https:\/\/kids.frontiersin.org\/articles\/10.3389\/frym.2019.00159 (Access: February 2025)","DOI":"10.3389\/frym.2019.00159"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Rayner C, Munckhof WJ. Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Intern Med J. 2005;35:S3-16. doi: 10.1111\/j.1444-0903.2005.00976.x.","DOI":"10.1111\/j.1444-0903.2005.00976.x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Tong Y, Zhang G, Zhang H, Ma S. Antibiotics synthesis: history and modern applications. Conference: Third International Conference on Biological Engineering and Medical Science (ICBioMed2023). 2024. p. 1292427. doi: 10.1117\/12.3021668","DOI":"10.1117\/12.3021668"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629-41. doi: 10.1038\/nrmicro2200.","DOI":"10.1038\/nrmicro2200"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Jokinen E, Laine J, Huttunen R, et al. Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillin-susceptible Staphylococcus aureus strains. Infect Dis (Auckl). 2017;49(7):493-500. doi: 10.1080\/23744235.2017.1292046.","DOI":"10.1080\/23744235.2017.1292046"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Lin P, Liu S, Cao Z, Zeng Y, Zhao Y, Li T, et al. An experimental study on the lytic bacteriophage MSP15 with wide-spectrum targeting methicillin-resistant Staphylococcus aureus. Virology 2025;605:110452. doi: 10.1016\/j.virol.2025.110452","DOI":"10.1016\/j.virol.2025.110452"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Mediavilla JR, Chen L, Mathema B, Kreiswirth BN. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol. 2012;15(5):588-95. doi: 10.1016\/j.mib.2012.08.003.","DOI":"10.1016\/j.mib.2012.08.003"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Lakhundi S, Zhang K. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev. 2018;31(4):10-1128.","DOI":"10.1128\/cmr.00020-18"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Alqahtani MSM, Shahin G, Abdelalim ITI, Khalaf SMH. Evaluation of ecological consequences on the global distribution of Staphylococcus aureus Rosenbach 1884 due to climate change, using Maxent modeling. Sci Rep. 2025;15(1):11457. doi: 10.1038\/s41598-025-87534-2.","DOI":"10.1038\/s41598-025-87534-2"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Lindsay JA. Hospital-associated MRSA and antibiotic resistance - what have we learned from genomics? Int J Med Microbiol. 2013;303(6-7):318-23. doi: 10.1016\/j.ijmm.2013.02.005.","DOI":"10.1016\/j.ijmm.2013.02.005"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19. Otto M. Community-associated MRSA: what makes them special? Int J Med Microbiol. 2013;303(6-7):324-30.","DOI":"10.1016\/j.ijmm.2013.02.007"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Said KB, Alshammari K, Ahmed RME, et al. MRSA Profiles Reveal Age- and Gender-Specificity in a Tertiary Care Hospital: High Burden in ICU Elderly and Emerging Community Patterns in Youth. Microorganisms. 2025;13(5):1-17. doi: 10.3390\/microorganisms13051078.","DOI":"10.3390\/microorganisms13051078"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Yang X, Zhang J, Yu S, Wu Q, Guo W, Huang J, et al. Prevalence of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in retail ready-toeat foods in China. Front Microbiol. 2016;7:816. doi: 10.3389\/fmicb.2016.00816.","DOI":"10.3389\/fmicb.2016.00816"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Pal M, Rebuma T, Regassa T, Zende R. Methicillin-Resistant Staphylococcus aureus (Mrsa) Remains a Major Threat to Public Health. Am J Public Heal Res. 2024;12(3):48-53.","DOI":"10.12691\/ajphr-12-3-2"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Lin JY, Lai JK, Chen JY, Cai JY, Yang ZD, Yang LQ, et al. Global insights into MRSA bacteremia: a bibliometric analysis and future outlook. Front Microbiol. 2024;15(January):1-19.","DOI":"10.3389\/fmicb.2024.1516584"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Lessa FC, Mu Y, Ray SM, et al. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections. Clin Infect Dis. 2012;55(2):232-41. doi: 10.1093\/cid\/cis408.","DOI":"10.1093\/cid\/cis408"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Zheng J, Shi W, Yang Q, Huang J, Shen J, Yin L, et al. Hospital-treated infectious diseases, infection burden and risk of Parkinson disease: An observational and Mendelian randomization study. Brain Behav Immun. 2024;120:352-9. doi: 10.1016\/j.bbi.2024.06.016.","DOI":"10.1016\/j.bbi.2024.06.016"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Hudzicki J. Kirby-Bauer Disk Diffusion Susceptibility Test Protocol Author Information. Am Soc Microbiol. 2012;(December 2009):1-13. Available from: https:\/\/asm.org\/getattachment\/2594ce26-bd44-47f6-8287-0657aa9185ad\/kirby-bauer-disk-diffusion-susceptibility-test-protocol-pdf (Access: January 2025)","DOI":"10.17504\/protocols.io.bpypmpvn"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Abdallah EM, Sulieman AME, Saleh ZA. New Discoveries in Toxins from Gram-Positive Bacteria Staphylococcus aureus BT \u2013 Microbial Toxins in Food Systems: Causes, Mechanisms, Complications, and Metabolism. In: Moneim Elhadi Sulieman A, Alshammari NI (ed). Cham: Springer Nature Switzerland; 2024. pp. 235-52. doi: 10.1007\/978-3-031-62839-9_18.","DOI":"10.1007\/978-3-031-62839-9_18"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Bashabsheh RHF, O\u2019la AF, Iyad N, Roba B, Rozan O. AK, and Bashabsheh HHF. Staphylococcus aureus epidemiology, pathophysiology, clinical manifestations and application of nano-therapeutics as a promising approach to combat methicillin resistant Staphylococcus aureus. Pathog Glob Health 2024 Apr 2;118(3):20931. doi: 10.1080\/20477724.2023.2285187","DOI":"10.1080\/20477724.2023.2285187"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Edwards AM, Massey RC. How does Staphylococcus aureus escape the bloodstream? Trends Microbiol. 2011;19(4):184-90. doi: 10.1016\/j.tim.2010.12.005.","DOI":"10.1016\/j.tim.2010.12.005"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. An N Van, Le Ha long H, Vu Huy L, et al. Antimicrobial Resistance Patterns of Staphylococcus aureus Isolated at a General Hospital in Vietnam Between 2014 and 2021. Infect Drug Resist. 2024 Jan 24:17:259-273. doi: 10.2147\/IDR.S437920. eCollection 2024.","DOI":"10.2147\/idr.s437920"},{"key":"ref30","unstructured":"31. Mehmood A, Bux H, Majeed A, Sameer N, Victor EN. Treatment of Staphylococcus aureus Infections in Humans by Phage Therapy as an Alternative to Antibiotics. Biological Times 2024;3(3):17-9."},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Pichereau S, Rose WE. Invasive community-associated MRSA infections: epidemiology and antimicrobial management. Expert Opin Pharmacother. 2010;11(18):3009-25. doi: 10.1517\/14656566.2010.511614.","DOI":"10.1517\/14656566.2010.511614"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Micek ST. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2007;45(Suppl 3):S184-90. doi: 10.1086\/519471.","DOI":"10.1086\/519471"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSA problem. Microbiol Spectr. 2019;7(2):10-1128. doi: 10.1128\/microbiolspec.GPP3-0057-2018.","DOI":"10.1128\/microbiolspec.gpp3-0057-2018"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Walsh TR, Efthimiou J, Dr\u00e9no B. Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. Lancet Infect Dis. 2016;16(3):e23-33. doi: 10.1016\/S1473-3099(15)00527-7.","DOI":"10.1016\/s1473-3099(15)00527-7"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Woodford N. Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci. Clin Microbiol Infect. 2005;11:2-21. doi: 10.1111\/j.1469-0691.2005.01140.x.","DOI":"10.1111\/j.1469-0691.2005.01140.x"}],"container-title":["Polski Merkuriusz Lekarski"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:58:04Z","timestamp":1760212684000},"score":1,"resource":{"primary":{"URL":"https:\/\/polskimerkuriuszlekarski.pl\/wp-content\/uploads\/library\/PolMerkurLek2025i5net.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.36740\/merkur202505108","archive":["Internet Archive"],"relation":{},"ISSN":["1426-9686"],"issn-type":[{"value":"1426-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}